Table 2.
Type of Metabolic Disorder | Conditions; Gene | Region; Age | Inheritance Pattern | Mov Disord | Key Findings | Seizures | Ataxia | Pyramidal signs | DD | Other Sx | I and L | Tx |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Organic acidemias | Glutaric aciduria type 1; GCDH | Neonatal | AR | Choreo-athetosis Dystonia Orofacial dyskinesia |
Macrocephaly Acute encephalopatic crisis Opisthotonus |
Yes | No | No | Yes | No | L: urinary glutaric acid, 3-hydroxyglutaric acid, glutaconic acid. | Low lysine diet and oral carnitine supplementation |
Propionic acidemia; PCCA and PCCB | Amish, Inuit of Greenland and Saudi Arabian populations; Neonatal or infancy | AR | Choreoathetosis | Poor feeding Lethargy Encephalopathy Vomiting Hypotonia |
Yes | No | Yes | Yes | Hepatomegaly Failure to thrive Optic atrophy Hearing loss Premature ovarian failure Chronic renal failure Cardiomyopathy Attention-deficit disorder Autism |
L: Plasma amino acids, acylcarnitines, and urinary organic acids, and orotic acid. I: Lesions in the bilateral lenticular and caudate nuclei | Protein-restricted diet; Treat metabolic acidosis, hypoglycemia, hyperammonemia | |
Methylmalonic acidemia; MUT | First year | AR | Choreoathetosis Dystonia |
Encephalopathy Stroke Hypotonia Lethargy Monilial infections |
Yes | No | No | Yes | Dysphagia Dysarthria Failure to thrive Hepatosplenomegaly |
L: Elevated blood and urine levels of ammonia, glycine, methylmalonic acid, propionic acid. I: Bilateral globus pallidus lesions |
Protein-restricted diet, cyanocobalamin, and levo-carnitine supplementation | |
OPA3-related 3-methylglutaconic aciduria (Costeff syndrome); OPA3 | Iraqi-Jewish descent; Before age ten years | AR | Choreoathetosis | Optic atrophy Spastic paraparesis |
No | Yes | No | No | No | L: Urinary excretion of 3-methylglutaconic acid | Supportive | |
Amino acid metabolism | Nonketotic hyperglycinemia; GLDC or AMT | Neonatal, infancy, adulthood | AR | Chorea | Lethargy, coma Hypotonia, hiccups Myoclonic jerks |
Yes | No | Yes | Yes | Breathing/swallowing disorders | I: Elevated glycine levels in CSF and plasma. | Sodium benzoate Dextromethorphan Seizure management |
Homocystinuria; CBS MTHFR, MTR, MTRR, MMADHC | 1st or 2nd decade | AR | Chorea Dystonia |
Ectopia lentis, severe myopia Thromboembolism Skeletal and skin abnormalities |
Yes | No | No | Yes | No | L: Increased serum levels of homocysteine and methionine | Vitamin B6 Methionine-restricted diet Folate Vitamin B12 Betaine |
|
Purine metabolism | Lesch-Nyhan disease; HPRT1 | 3 to 6 mo. | X-linked | Choreoathetosis Dystonia |
Self-injurious behavior Gouty arthritis Crystals or calculi in kidneys, ureters, bladder |
No | No | Yes | Yes | Hypotonia Behavioral disturbances |
L: Urinary urine-to-creatine ratio greater than 2.0 Hyperuricemia Hyperuricuria |
Allopurinol Symptomatic |
Creatine metabolism | Cerebral creatine deficiency syndrome 2 (GAMT deficiency); GAMT | Early infancy to 3 yrs. | AR | Choreoathetosis Dystonia |
Hyperactivity, autism, self-injurious behavior | Yes | Yes | No | No | No | I: Hyperintensities in basal ganglia | Creatine monohydrate supplementation Ornithine supplementation Protein- or arginine-restricted diet |
Glucose transport | GLUT1 deficiency; SLC2A1 | Infancy | AD; AR | Chorea Dystonia |
Paroxysmal episodes of mov disord or epilepsy Atypical childhood absence epilepsy Myoclonic astatic epilepsy |
Yes | Yes | No | Yes | Microcephaly | L: Low CSF:serum glucose ratio | Ketogenic diet Symptomatic |
Lipid storage | Niemann Pick Type C; NPC1 or NPC2 | Infancy, children, adults | AR | HD phenocopy in adult onset Dystonia |
Vertical supranuclear gaze palsy Dementia |
Yes | Yes | No | Yes | Hypotonia Liver disease Respiratory failure |
I: cerebellar atrophy or periventricular hyperintensities | Symptomatic |
Other | Sulfite oxidase deficiency; SUOX | Infancy | AR | Choreoathetosis Dystonia |
Ectopia lentis Eczema Failure to thrive |
Yes | Yes | No | Yes | Hypotonia | L: Increase sulfite levels in urine I: Calcification of basal ganglia and cerebellar hypoplasia |
Low sulfur amino acid diet Low protein diet |
Mitochondrial cytopathies | Leigh syndrome and Leigh-like syndromes; MT-ND, MTATP6 | First mo. to yrs. of life | X-linked, AR | Choreoathetosis Dystonia Parkinsonism |
Ophthalmologic abnormalities Cardiac, hepatic, gastrointestinal and renal symptoms. |
No | Yes | No | Yes | Hypotonia | L: Increased blood lactate levels. I: T2-weighted hyperintensities in basal ganglia and brainstem. |
Biotin, thiamine, Coenzyme Q10 supplements |
Pyruvate carboxylase deficiency; PC | First yr. | AR | Choreoathetosis Tremors |
Microcephaly Disconjugate eye movements, poor pupillary response, blindness, poor visual tracking Respiratory abnormalities |
Yes | Yes | Yes | Yes | Hypotonia | L: Elevated blood levels of ammonia, pyruvate, lactate, acetoacetate and beta-hydroxybutyrate. I: periventricular WM cysts, subcortical FP hypernintensities. |
Cofactor supplementation with thiamine and lipoic acid and administration of dichloroacetate | |
Pyruvate dehydrogenase complex deficiency; PDHA1 | Infancy | X-linked | Choreoathetosis Dystonia |
Poor feeding Lethargy Tachypnea Abnormal eye movements Dysmorphic features Respiratory abnormalities |
Yes | Yes | Yes | Yes | Microcephaly Hypotonia |
L: Elevated blood levels of lactate and pyruvate I: absence of corpus callosum and medullary pyramids, ectopic inferior olives, symmetric cystic lesions and gliosis, generalized hypomyelination. |
Cofactor supplementation with thiamine, carnitine, and lipoic acid. |
Mov Dis: Movement Disorders; Sx: Symptoms; DD: Developmental delay; I: Imaging; L: Laboratory; AR: Autosomal recessive; AD: Autosomal dominant; CSF: cerebrospinal fluid; WM: white matter; FP: frontoparietal.
* Only the disorders of metabolism where chorea is the predominant movement disorder are included.
* Wilson’s disease is described under autosomal recessive hereditary choreas.